165 related articles for article (PubMed ID: 8120412)
1. Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin.
Quinn AG; Campbell C; Healy E; Rees JL
J Invest Dermatol; 1994 Mar; 102(3):300-3. PubMed ID: 8120412
[TBL] [Abstract][Full Text] [Related]
2. Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers.
Quinn AG; Sikkink S; Rees JL
Genes Chromosomes Cancer; 1994 Dec; 11(4):222-5. PubMed ID: 7533525
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss.
Quinn AG; Sikkink S; Rees JL
Cancer Res; 1994 Sep; 54(17):4756-9. PubMed ID: 8062275
[TBL] [Abstract][Full Text] [Related]
4. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.
Holmberg E; Rozell BL; Toftgård R
Br J Cancer; 1996 Jul; 74(2):246-50. PubMed ID: 8688329
[TBL] [Abstract][Full Text] [Related]
5. Allele loss on chromosome 9q22.2-22.3 in sporadic basal cell carcinoma in Chinese.
He C; Zhang X; Wang Y; Sun K; Chen HD
Chin Med J (Engl); 1999 Jun; 112(6):497-500. PubMed ID: 11601325
[TBL] [Abstract][Full Text] [Related]
6. Allelic imbalance studies of chromosome 9 suggest major differences in chromosomal instability among nonmelanoma skin carcinomas.
Gomes GP; Moraes AM; Stoff HO; Ward LS
Sao Paulo Med J; 2004 Jan; 122(1):18-21. PubMed ID: 15160522
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
8. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of loss of heterozygosity at the nevoid basal cell carcinoma locus and other selected loci in appendageal tumors.
Takata M; Quinn AG; Hashimoto K; Rees JL
J Invest Dermatol; 1996 May; 106(5):1141-4. PubMed ID: 8618054
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.
Saridaki Z; Liloglou T; Zafiropoulos A; Koumantaki E; Zoras O; Spandidos DA
Br J Dermatol; 2003 Apr; 148(4):638-48. PubMed ID: 12752119
[TBL] [Abstract][Full Text] [Related]
11. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer.
Sikkink SK; Rehman I; Rees JL
J Invest Dermatol; 1997 Dec; 109(6):801-5. PubMed ID: 9406824
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53 gene mutations and loss of heterozygosity for loci on chromosome 9q in basal cell carcinoma.
Konishi K; Yamanishi K; Ishizaki K; Yamada K; Kishimoto S; Yasuno H
Cancer Lett; 1994 Apr; 79(1):67-72. PubMed ID: 8187055
[TBL] [Abstract][Full Text] [Related]
13. Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-centimorgan interval of the distal long arm of chromosome 9.
Miura K; Okita K; Furukawa Y; Matsuno S; Nakamura Y
Cancer Res; 1995 May; 55(9):1828-30. PubMed ID: 7728747
[TBL] [Abstract][Full Text] [Related]
14. No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung.
Suzuki K; Daigo Y; Fukuda S; Tokino T; Isomura M; Isono K; Wainwright B; Nakamura Y
Jpn J Cancer Res; 1997 Mar; 88(3):225-8. PubMed ID: 9140104
[TBL] [Abstract][Full Text] [Related]
15. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.
Saridaki Z; Koumantaki E; Liloglou T; Sourvinos G; Papadopoulos O; Zoras O; Spandidos DA
J Invest Dermatol; 2000 Oct; 115(4):719-25. PubMed ID: 10998150
[TBL] [Abstract][Full Text] [Related]
16. Nevoid basal cell carcinoma syndrome.
Bale AE; Gailani MR; Leffell DJ
J Invest Dermatol; 1994 Nov; 103(5 Suppl):126S-130S. PubMed ID: 7963674
[TBL] [Abstract][Full Text] [Related]
17. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.
Waring AJ; Takata M; Rehman I; Rees JL
Br J Cancer; 1996 Mar; 73(5):649-53. PubMed ID: 8605102
[TBL] [Abstract][Full Text] [Related]
19. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the c-Ha-ras-1 allele in human skin cancers.
Ananthaswamy HN; Applegate LA; Goldberg LH; Bales ES
Mol Carcinog; 1989; 2(5):298-301. PubMed ID: 2690853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
